To investigate the clinical value of combined detection of carcinoembryonic antigen(CEA) and CA125 in the diagnosis of non-small cell lung cancer(NSCLC) combined with malignant pleural effusion. This evidence concerns the gene CEACAM5 and non-small cell lung carcinoma.